Nektar Therapeutics (NKTR)
43.58
-3.41
(-7.26%)
USD |
NASDAQ |
Oct 02, 16:00
43.40
-0.18
(-0.41%)
After-Hours: 20:00
Nektar Therapeutics EPS Diluted (Quarterly) : -1.229 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.229 |
| March 31, 2026 | -1.815 |
| December 31, 2025 | -1.778 |
| September 30, 2025 | -1.875 |
| June 30, 2025 | -2.952 |
| March 31, 2025 | -0.2412 |
| December 31, 2024 | 0.5099 |
| September 30, 2024 | -0.1771 |
| June 30, 2024 | -0.2507 |
| March 31, 2024 | -0.189 |
| December 31, 2023 | -0.2203 |
| September 30, 2023 | -0.2407 |
| June 30, 2023 | -0.2696 |
| March 31, 2023 | -0.7254 |
| December 31, 2022 | -0.3171 |
| September 30, 2022 | -0.3147 |
| June 30, 2022 | -0.8515 |
| March 31, 2022 | -0.4864 |
| December 31, 2021 | -0.7874 |
| September 30, 2021 | -0.7045 |
| June 30, 2021 | -0.687 |
| March 31, 2021 | -0.678 |
| December 31, 2020 | -0.6523 |
| September 30, 2020 | -0.6063 |
| June 30, 2020 | -0.4486 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.7825 |
| December 31, 2019 | -0.6368 |
| September 30, 2019 | -8.431 |
| June 30, 2019 | -9.477 |
| March 31, 2019 | -10.32 |
| December 31, 2018 | -0.5668 |
| September 30, 2018 | -0.5567 |
| June 30, 2018 | 5.329 |
| March 31, 2018 | -0.5954 |
| December 31, 2017 | -0.2136 |
| September 30, 2017 | 0.3743 |
| June 30, 2017 | -0.3854 |
| March 31, 2017 | -0.4156 |
| December 31, 2016 | -0.2831 |
| September 30, 2016 | -0.3153 |
| June 30, 2016 | -0.3565 |
| March 31, 2016 | -0.1436 |
| December 31, 2015 | -0.4035 |
| September 30, 2015 | -0.0618 |
| June 30, 2015 | -0.40 |
| March 31, 2015 | 0.2493 |
| December 31, 2014 | -0.3532 |
| September 30, 2014 | 0.5342 |
| June 30, 2014 | -0.2569 |
| March 31, 2014 | -0.374 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| Inovio Pharmaceuticals, Inc. | -0.0737 |
| Tonix Pharmaceuticals Holding Corp. | -2.438 |
| Capricor Therapeutics, Inc. | -0.7032 |
| Kyntra Bio, Inc. | 2.958 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.62M |
| Revenue (Quarterly) | 10.13M |
| Total Expenses (Quarterly) | 50.75M |
| Enterprise Value | 938.97M |
| Gross Profit Margin (Quarterly) | 98.46% |
| Profit Margin (Quarterly) | -401.0% |
| Earnings Yield | -15.37% |
| Normalized Earnings Yield | -14.60 |